Aims: To perform a large and detailed epidemiologic study on restless legs syndrome (RLS) during pregnancy in a European country. Methods: A cross-sectional questionnaire survey. The questionnaire was distributed by the medical staff in different outpatient waiting rooms (obstetrics and gynecology department of the university hospital, obstetrics and gynecology department of a private clinic, private midwives, private obstetrician-gynecologists, radiological centers before fetal ultrasound examination and general practitioners) in a French town and its surrounding area (200,000 inhabitants): A woman was considered affected if she met the International RLS Study Group criteria for RLS diagnosis. Results: 1,022 pregnant women living in a French town were included. 24% of women were affected by RLS during their pregnancy. The disease was strongly related to the third trimester of pregnancy and had a significant impact on sleep leading to severe nocturnal and diurnal consequences with a high consumption of sleep medication. Conclusions: RLS affects one quarter of pregnant women, essentially during the third trimester and represents an important public health issue with sleep medication intake.

Keywords:
Pregnancy, Restless legs syndrome
1.
Lee KA: Alterations in sleep during pregnancy and postpartum: a review of 30 years of research. Sleep Med Rev 1998;2:231–242.
2.
Hedman C, Pohjasvaara T, Tolonen U, et al: Effect of pregnancy on mother’s sleep. Sleep Med 2002;3:37–42.
3.
Moline ML, Borch L, Zak R, et al: Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 2003;7:155–177.
4.
Pien GW, Schwab RJ: Sleep disorders during pregnancy. Sleep 2004;27:1405–1417.
5.
Izci B, Martin SE, Dundas KC, et al: Sleep complaints: snoring and daytime sleepiness in pregnant and pre-eclamptic women. Sleep Med 2005;6:163–169.
6.
Brunner DP, Munch M, Biedermann K, et al: Changes in sleep and sleep electroencephalogram during pregnancy. Sleep 1994;17:576–582.
7.
Neau JP, Texier B, Ingrand P: Sleep and vigilance disorders in pregnancy. Eur Neurol 2009;62:23–29.
8.
Manconi M, Govoni V, De Vito A, et al: Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004;5:305–308.
9.
Ekbom KA: Restless legs syndrome. Acta Med Scand 1945;158(suppl):4–122.
10.
Jolivet B: Paresthésies nocturnes agitantes des members inférieurs. Thèse de Médecine, Paris 1953.
11.
Ekbom K: Acroparesthesia and restless legs in pregnancy. Sven Lakartidn 1960;57:2597–2603.
12.
Goodman JDS, Brodie C, Ayida GA: Restless leg syndrome in pregnancy. BMJ 1988;297:1101–1102.
13.
Suzuki K, Ohida T, Sone T, et al: The prevalence of restless legs syndrome among pregnant women in Japan and relationship between restless legs syndrome and sleep problems. Sleep 2003;26:673–677.
14.
Manconi M, Govoni V, De Vito A, et al: Restless legs syndrome and pregnancy. Neurology 2004;63:1065–1069.
15.
Tunc T, Karadag YS, Dogulu F, Inan LE: Predisposing factors of restless legs syndrome in pregnancy. Mov Dis 2007;22:627–631.
16.
Herraiz de Castro C, Martinez FG, Angulo AMB, Alejo MA: Sindrome de las piernas inquietas en el embarazo. Sven Lakartidn 1960;57:2597–2603.
17.
Sikandar R, Khealani BA, Wasay M: Predictors of restless legs syndrome in pregnancy: a hospital-based cross-sectional survey in Pakistan. Sleep Med 2009;10:676–678.
18.
Allen RP, Picchietti D, Hening WA, et al: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101–119.
19.
The International Restless Legs Syndrome Study Group: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121–132.
20.
Walters AS: The International Restless Legs Study Group. Towards a better definition of the restless legs syndrome. Mov Disord 1995;10:634–642.
21.
Tison F, Crochard A, Léger D, Bouée S, Lainey E, El Hasnaoui A: Epidemiology of restless legs syndrome in French adults. A nationwide survey: The INSTANT study. Neurology 2005;65:239–246.
22.
Philips B, Young T, Finn L, et al: Epidemiology of restless legs syndrome in adults. Arch Intern Med 2000;160:2137–2141.
23.
Berger K, Luedemann J, Trenkwalter C, John U, Kessler C: Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196–202.
24.
Lee KA, Zaffke ME, Baratte-Beebe K: Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gen Med 2001;10:335–341.
25.
Ghorayeb I, Bioulac B, Scribans C, Tison F: Perceived severity of restless legs syndrome across the female life cycle. Sleep Med 2008;9:799–802.
26.
Nikkola E, Ekblad U, Ekholm E, et al: Sleep in multiple pregnancy. Breathing patterns, oxygenation, and periodic leg movements. Am J Obstet Gynecol 1996;174:1622–1625.
27.
Dzaja A, Wehrle R, Lancel M, Pollmächer T: Elevated estradiol plasma levels in women with restless legs syndrome. Sleep 2009;32:169–174.
28.
Pantaleo NP, Hening WA, Allen RP, Earley CJ: Pregnancy accounts for most of the gender difference in prevalence of familial RLS. Sleep Med 2010;11:310–313.
29.
Puolakka J, Jänne O, Pakarinen A, Vihko R: Serum ferritin in the diagnosis of anemia during pregnancy. Acta Obstet Gynecol Scand 1980;95(suppl):57–63.
30.
Botez MI, Lambert B: Folate deficiency and restless legs syndrome in pregnancy. N Engl J Med 1977;297:670.
31.
Wetter TC, Collado-Seidel V, Oertel H, Uhr M, Yassouridis A, Trenkwalter C: Endocrine rhythms in patients with restless legs syndrome. J Neurol 2002;249:146–151.
32.
Walters AS, Wagner M, Hening WA: Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy. Sleep 1996;19:825–826.
33.
Djokanovic N, Garcia-Bournissen F, Koren G: Medications for restless legs syndrome in pregnancy. J Obstet Gynaecol Can 2008;30:505–507.
34.
Hensley JG: Legs cramps and restless legs syndrome during pregnancy. J Midwifery Womens Health 2009;54:211–218.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.